You are here: Industry Insights > Carlyle

News List

Healthcare industry reports 106 deals worth $49.7 billion in June 2021 expresspharma
July 08, 2021
In June 2021, the healthcare industry reported 106 deals worth $49.7 billion as compared to the last 12-month average (June 2020 to May 2021) of 104 deals worth $23.4 billion.
Carlyle Group to acquire pharma company Vectura for $1.36bn pharmaceutical-technology
May 28, 2021
Carlyle Group has entered an agreement, through which its affiliate Murano Bidco will acquire 100% shares of pharmaceutical firm Vectura Group in a deal worth $1.36bn (£958m).
Piramal Pharma announces completion of 20 per cent strategic growth investment by Carlyle expresspharma
October 12, 2020
Carlyle completes investment in Piramal Pharma; capital infusion to accelerate Piramal Pharma’s organic and inorganic growth plans.
CII approves Carlyle’s acquisition of stake in Piramal Pharma for $490m pharmaceutical-technology
September 15, 2020
The Competition Commission of India (CCI) has approved the sale of 20% of the issued and paid-up equity share capital in Piramal Pharma, a subsidiary of Piramal Enterprises, to Carlyle Group for approximately $490m.
Carlyle to acquire stake in China’s Salubris Pharmaceutical for $260m pharmaceutical-technology
September 04, 2020
US-based investment firm Carlyle Group has entered an agreement to acquire a 5% stake in Chinese biopharmaceutical firm Shenzhen Salubris Pharmaceutical.
Carlyle Pays $490M for 20% of Piramal Pharma contractpharma
July 06, 2020
Will integrate Piramal Enterprises’ pharma businesses into its subsidiary Piramal Pharma Limited.
The Carlyle Group to acquire majority stake in SeQuent Scientific expresspharma
May 11, 2020
The transaction is expected to close in the third quarter of 2020, subject to customary closing conditions and regulatory approvals.